Dr. John Maloney is Senior Vice President of Research & Development and is a member of the Exela Leadership Team.
John joined Exela in March of 2013, bringing more than 25 years of pharma Research & Development experience. His extensive R&D history includes positions at Sterling Winthrop, Alpharma, Taro Pharmaceuticals, Harmony Labs, Sandoz and TPDA.
Maloney is credited with developing and submitting numerous Abbreviated New Drug Applications (ANDA’s) to the FDA as well as OTC/DESI products submitted for approvals in both U.S. and European markets.
John Maloney received a Ph. D. from State University of New York, Buffalo, where he continues Post-Doctoral studies.